MyFinsight
Home
Blog
About
Medpace Holdings, Inc. (MEDP)
Medpace Holdings, Inc. (MEDP)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$149,993K
Free Cash flow
$138,100K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Net income
Advanced billings
Accrued expenses
Others
Negative Cash Flow Breakdown
Repurchases of common stock
Accounts receivable and unbilled...
Property and equipment expenditu...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income
121,362
123,870
135,133
111,135
Depreciation
6,555
6,751
6,894
6,813
Amortization
155
155
237
236
Stock-based compensation expense
4,348
4,918
5,620
6,323
Noncash lease expense
6,053
5,849
5,685
5,642
Income tax provision (benefit), deferred
-
-
80,773
-
Deferred income tax provision
4,281
-44,823
-
28,510
Other
145
-400
442
-87
Accounts receivable and unbilled, net
47,183
-7,822
29,096
-4,861
Prepaid expenses and other current assets
14,154
1,795
11,494
-17,523
Accounts payable
-129
84
1,333
-10,725
Accrued expenses
45,017
-1,300
39,562
45,272
Advanced billings
48,378
1,954
20,062
25,545
Lease liabilities
-7,063
-5,294
-7,029
-5,516
Other assets and liabilities, net
5,464
10,169
-8,780
-10,503
Net cash provided by operating activities
162,011
151,788
192,652
246,209
Property and equipment expenditures
23,911
6,814
4,536
10,713
Other
-26
-66
-63
-53
Net cash used in investing activities
-23,885
-6,748
-4,473
-10,660
Proceeds from stock option exercises
6,424
12,670
22,729
7,987
Repurchases of common stock
294,764
0
0
4,574
Proceeds from revolving loan
-
-
0
-
Payments on revolving loan
-
-
0
-
Net cash used in financing activities
-288,340
12,670
22,729
3,413
Effect of exchange rates on cash, cash equivalents, and restricted cash
221
-2,078
790
59
Increase (decrease) in cash, cash equivalents, and restricted cash
-149,993
155,632
211,698
239,021
Cash, cash equivalents, and restricted cash beginning of period
652,681
497,049
285,351
669,436
Cash, cash equivalents, and restricted cash end of period
502,688
652,681
497,049
285,351
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net income
$121,362K
(-40.76%↓ Y/Y)
Advanced billings
$48,378K
(-50.73%↓ Y/Y)
Accrued expenses
$45,017K
(267.52%↑ Y/Y)
Depreciation
$6,555K
(-51.34%↓ Y/Y)
Noncash lease expense
$6,053K
(-48.21%↓ Y/Y)
Stock-based compensation
expense
$4,348K
(-80.97%↓ Y/Y)
Deferred income tax
provision
$4,281K
(-87.72%↓ Y/Y)
Amortization
$155K
(-67.23%↓ Y/Y)
Net cash provided by
operating activities
$162,011K
(-40.95%↓ Y/Y)
Effect of exchange
rates on cash, cash...
$221K
(-95.64%↓ Y/Y)
Canceled cashflow
$74,138K
Increase (decrease) in
cash, cash...
-$149,993K
(75.93%↑ Y/Y)
Canceled cashflow
$162,232K
Proceeds from stock
option exercises
$6,424K
(-75.56%↓ Y/Y)
Other
-$26K
(74.00%↑ Y/Y)
Accounts receivable and
unbilled, net
$47,183K
(-42.45%↓ Y/Y)
Prepaid expenses and
other current assets
$14,154K
(-57.28%↓ Y/Y)
Lease liabilities
-$7,063K
(44.01%↑ Y/Y)
Other assets and
liabilities, net
$5,464K
(-32.09%↓ Y/Y)
Other
$145K
(-72.12%↓ Y/Y)
Accounts payable
-$129K
(-101.07%↓ Y/Y)
Net cash used in
financing activities
-$288,340K
(67.48%↑ Y/Y)
Canceled cashflow
$6,424K
Net cash used in
investing activities
-$23,885K
(-49.22%↓ Y/Y)
Canceled cashflow
$26K
Repurchases of common stock
$294,764K
(-67.71%↓ Y/Y)
Property and equipment
expenditures
$23,911K
(48.45%↑ Y/Y)
Buy us a coffee